Detalles de la búsqueda
1.
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Blood
; 142(22): 1871-1878, 2023 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37494698
2.
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee.
Lancet Oncol
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821074
3.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer
; 130(3): 439-452, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795845
4.
Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE.
Blood
; 139(4): 492-501, 2022 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34269818
5.
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA.
Blood
; 139(6): 835-844, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34289038
6.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood
; 140(11): 1229-1253, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35653592
7.
Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone.
Haematologica
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38426294
8.
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma.
BMC Cancer
; 24(1): 541, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38684948
9.
Venetoclax in biomarker-selected multiple myeloma patients: Impact of exposure on clinical efficacy and safety.
Hematol Oncol
; 42(1): e3222, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740931
10.
Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines.
Ann Hematol
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630132
11.
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(1D): e240001, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244272
12.
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders.
Eur J Haematol
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804098
13.
High-risk multiple myeloma: Redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy.
Am J Hematol
; 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613829
14.
Three-dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma.
Am J Hematol
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38747543
15.
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Int J Cancer
; 152(2): 239-248, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082445
16.
Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
Cancer
; 129(3): 385-392, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36413412
17.
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
Cancer
; 129(14): 2179-2191, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021929
18.
Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma.
Oncologist
; 28(5): e263-e269, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37002943
19.
Photon-counting Detector CT with Deep Learning Noise Reduction to Detect Multiple Myeloma.
Radiology
; 306(1): 229-236, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36066364
20.
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Blood
; 137(26): 3616-3628, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33763699